A Utah company, CivicaScript, is revolutionizing the generic drug market by offering affordable options for patients. Recent reports show that prostate cancer patients who switched to CivicaScript-produced abiraterone acetate saved an average of $81 per month and experienced more consistent monthly costs. Additionally, healthcare plans saw significant savings of $1,796 per month for patients using […]